Literature DB >> 24244806

Striking similarities in genetic aberrations between a rectal tumor and its lung recurrence.

Osama E Rahma1, Mauricio Burotto, Luisa Matos Do Canto, Alexandre A Germanos, Bassem R Haddad, John L Marshall.   

Abstract

We are reporting on a colorectal cancer patient with the longest disease-free interval ever published, where chromosomal microarray analysis was used to confirm the link between the primary and metastatic lesions. This rare case reports on a patient with late recurrence of colorectal cancer in the lung 19 years after its initial diagnosis. We used high-resolution array CGH (aCGH) to analyze the genetic aberrations of both the primary rectal and the recurrent metastatic lung lesions. Interestingly, we found striking similarities between the two lesions, despite the 19 years disease-free interval. In addition, most of the genes that were previously reported to be associated with a high recurrence score showed copy number gains by aCGH in one or both lesions. Our findings suggest that aCGH may be a helpful tool in analyzing the origin of metastases and underline the need for a better understanding of the characteristics of rectal tumors that have a late recurrence potential.

Entities:  

Keywords:  Colorectal cancer; Delayed; Genetic aberrations; High-resolution array CGH.; Recurrence

Year:  2013        PMID: 24244806      PMCID: PMC3828635          DOI: 10.4251/wjgo.v5.i11.198

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  22 in total

1.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

2.  Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.

Authors:  Jeng-Kai Jiang; Yann-Jang Chen; Chi-Hung Lin; I-Ting Yu; Jen-Kou Lin
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

Review 3.  The dormancy dilemma: quiescence versus balanced proliferation.

Authors:  Alan Wells; Linda Griffith; Jakob Z Wells; Donald P Taylor
Journal:  Cancer Res       Date:  2013-06-21       Impact factor: 12.701

4.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.

Authors:  P C Simmonds
Journal:  BMJ       Date:  2000-09-02

5.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

Review 6.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

7.  Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

Authors:  Arnaud D Roth; Sabine Tejpar; Mauro Delorenzi; Pu Yan; Roberto Fiocca; Dirk Klingbiel; Daniel Dietrich; Bart Biesmans; György Bodoky; Carlo Barone; Enrique Aranda; Bernard Nordlinger; Laura Cisar; Roberto Labianca; David Cunningham; Eric Van Cutsem; Fred Bosman
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

8.  Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.

Authors:  N Wolmark; B Fisher; H Rockette; C Redmond; D L Wickerham; E R Fisher; J Jones; A Glass; H Lerner; W Lawrence
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

9.  Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.

Authors:  Arnaud D Roth; Mauro Delorenzi; Sabine Tejpar; Pu Yan; Dirk Klingbiel; Roberto Fiocca; Giovanni d'Ario; Laura Cisar; Roberto Labianca; David Cunningham; Bernard Nordlinger; Fred Bosman; Eric Van Cutsem
Journal:  J Natl Cancer Inst       Date:  2012-10-25       Impact factor: 13.506

10.  Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

Authors:  Michael J O'Connell; Megan E Campbell; Richard M Goldberg; Axel Grothey; Jean-François Seitz; Jacqueline K Benedetti; Thierry André; Daniel G Haller; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2008-05-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.